Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6XOS

CryoEM structure of human presequence protease in partial open state 1

Summary for 6XOS
Entry DOI10.2210/pdb6xos/pdb
EMDB information22278 22279 22280 22281 22282
DescriptorPresequence protease, mitochondrial (1 entity in total)
Functional Keywordspartial open state, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight114901.46
Authors
Liang, W.G.,Zhao, M.,Tang, W. (deposition date: 2020-07-07, release date: 2021-07-07, Last modification date: 2024-05-15)
Primary citationLiang, W.G.,Wijaya, J.,Wei, H.,Noble, A.J.,Mancl, J.M.,Mo, S.,Lee, D.,Lin King, J.V.,Pan, M.,Liu, C.,Koehler, C.M.,Zhao, M.,Potter, C.S.,Carragher, B.,Li, S.,Tang, W.J.
Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition.
Nat Commun, 13:1833-1833, 2022
Cited by
PubMed Abstract: Presequence protease (PreP), a 117 kDa mitochondrial M16C metalloprotease vital for mitochondrial proteostasis, degrades presequence peptides cleaved off from nuclear-encoded proteins and other aggregation-prone peptides, such as amyloid β (Aβ). PreP structures have only been determined in a closed conformation; thus, the mechanisms of substrate binding and selectivity remain elusive. Here, we leverage advanced vitrification techniques to overcome the preferential denaturation of one of two ~55 kDa homologous domains of PreP caused by air-water interface adsorption. Thereby, we elucidate cryoEM structures of three apo-PreP open states along with Aβ- and citrate synthase presequence-bound PreP at 3.3-4.6 Å resolution. Together with integrative biophysical and pharmacological approaches, these structures reveal the key stages of the PreP catalytic cycle and how the binding of substrates or PreP inhibitor drives a rigid body motion of the protein for substrate binding and catalysis. Together, our studies provide key mechanistic insights into M16C metalloproteases for future therapeutic innovations.
PubMed: 35383169
DOI: 10.1038/s41467-022-29322-4
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.7 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon